Alcohol abuse and dependence: Neurobiology and clinical implications

Economics of Neuroscience

Volumn 3, Issue 12, 2001, Pages 29-36

  Petrakis, Ismene L ^a   Tabakoff, Boris ^a   Krystal, John H ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; 5 HYDROXYINDOLEACETIC ACID; ACAMPROSATE; ALCOHOL; AMPA RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ENDORPHIN; CALCIUM CHANNEL; CANNABIS; COCAINE; DELTA OPIATE RECEPTOR; DEXAMPHETAMINE; DOPAMINE; FLUMAZENIL; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KETAMINE; METHAMPHETAMINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; NORADRENALIN; OPIATE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; UNINDEXED DRUG; YOHIMBINE;

ALCOHOL ABUSE; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CELL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; DEPRESSION; DRINKING BEHAVIOR; EUPHORIA; FAMILY HISTORY; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDICAL RESEARCH; NEUROBIOLOGY; NONHUMAN; RELAPSE; RISK ASSESSMENT; SEDATION; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

EID: 0035720324     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (141)

1. Inhibitory synapses. Anaesthetics set their sites on ion channels
2. Sites of alcohol and volatile anaesthetic action on GABA (A) and glycine receptors
3. Ascending and descending rates of change in blood alcohol concentrations and subjective intoxication ratings
4. Acute alcohol intoxication and cognitive functioning
5. Simple reaction time event-related potentials: Effects of alcohol and diazepam
6. Genetic differences in psychomotor performance decrement after alcohol: A multivariate analysis
7. Antisocial personality disorder and alcohol-induced aggression
8. Effect of drugs and alcohol on psychomotor skills related to driving
9. Complications of alcohol withdrawal: Pathophysiological insights Alcohol
10. Symptomology in alcoholics at various stages of abstinence
11. The Korsakoff syndrome
12. Receptor and ion channel nomenclature
13. Cellular and behavioral neurobiology of alcohol: Receptor-mediated neuronal processes
14. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol
15. Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens
16. Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures
17. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures
18. Effects of ethanol and NMDA antagonists on operant behavior in ethanol withdrawal seizure-prone and -resistant mice
19. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal
20. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine ethanol withdrawal seizures
21. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics
22. Differentiating NMDA dysregulation in schizophrenia and alcoholism using ketamine
23. Dextromethorphan challenge in alcohol-dependent patients and controls
24. Glutamate receptor changes in brain synaptic membranes from human alcoholics
25. The glutamatergic basis of human alcoholism
26. Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis
27. Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: Modulation by yohimbine and m-chlorophenylpiperazine (mCPP)
28. NMDA dysregulation in individuals with a family vulnerability to alcoholism
29. Anti-craving compounds for ethanol: New pharmacological tools to study addictive processess
30. Acamprosate: New preclinical and clinical findings
31. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis
32. Ethanol potentiates gamma-aminobutyric acid-mediated inhibition in the inferior colliculus: Evidence for local ethanol/gamma-aminobutyric acid interactions
33. Molecular genetic analysis of the role of GABAergic systems in the behavioral and cellular actions of alcohol
34. Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal
35. Preliminary evidence of reduced cortical GABA levels in localized 1H NMR spectra of alcohol dependent and hepatic encephalopathy patients
36. Plasma gamma-aminobutyric acid (GABA) is low in alcoholics
37. GABA receptors are increased in brains of alcoholics
38. A receptors in the actions of alcohol and in alcoholism: Recent advances
39. Decrease of benzodiazepine receptors in frontal cortex of alcoholics
40. Receptor binding sites and uptake activities mediating GABA neurotransmission in chronic alcoholics with Wernicke encephalophaty
41. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics
42. Alterations of benzodiazepine receptors in type II alcoholics measured with SPECT and [123I]iomazenil
43. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy
44. Decreased cerebral response to inhibitory neurotransmission in alcoholics
45. Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification
46. Eye movement effects of diazepam-in sons of alcoholic fathers and male control subjects
47. Alcohol challenges in young men from alcoholic pedigrees and control families: A report from the COGA project
48. Ethanol self-administration in males with and without an alcoholic first-degree relative
49. Diazepam preference in males with and without an alcoholic firstdegree relative
50. Preferences for ethanol and diazepam in anxious individuals: An evaluation of the self-medication hypothesis
51. Benzodiazepines in the treatment of alcoholism
52. Efficacy of flumazenil in acute alcohol intoxication: Double blind placebo-controlled evaluation
53. Flumazenil in alcohol withdrawal: A double-blind placebo-controlled study
54. Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose
55. Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists
56. Inheritance of alcohol abuse. Crossfostering analysis of adopted men
57. Platelet MAO activity as a biological marker in subgroups of alcoholism
58. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms
59. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics
60. Behavioral and neuroendocrine responses to-m-chlorophenypiperazine in subtypes of alcoholics and in healthy comparison subjects
61. The metachlorophenylpiperazine challenge test in cocaine addicts: Hormonal and psychological responses
62. Reduced central serotonin turnover in a subgroup of alcoholics?
63. Age of alcoholism onset. II. Relationship to susceptibility to serotonin precursor availability
64. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects
65. TPH replication study: Not!
66. Dopamine D1, D2 and D3 receptor genes in alcohol dependence
67. Suicidality and 5-hydroxyin-doleacetic acid concentration associated with a tryptophan hydroxylase polymorphism
68. Ethanol intake and 3H-serotonin uptake. II: A study in alcoholic patients using platelets 3H-paroxetine binding
69. Platelet serotonin uptake in men with family histories of alcoholism
70. Neuroscience: Implications of treatment
71. Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence
72. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
73. Fluoxetine attenuates alcohol intake and desire to drink
74. Ritanserin in the treatment of alcohol dependence-A multi-center clinical trial
75. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
76. A placebo-controlled trial of buspirone in anxious inpatient alcoholics
77. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients-A randomized controlled trial
78. Ondansetron alters human alcohol intoxication
79. Cellular and molecular mechanisms of drug dependence
80. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants
81. Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding
82. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens
83. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats
84. Marked decrease of extraneuronal dopamine after alcohol withdrawal in rats: Reversal by MK-801
85. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal
86. The locus coeruleus in the rat: An immunohistochemical delineation
87. Low doses of ethanol disrupt sensory responses to brain noradrenergic neurons
88. Basal firing of rat locus coeruleus neurons affects sensitivity to ethanol
89. Effect of alcohol on neurotransmitters and their receptors and enzymes
90. Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man
91. Interaction between ethanol and dextroamphetamine: Effects on psychomotor performance
92. Noradrenergic response to acute ethanol administration in healthy subjects: Comparison with intravenous yohimbine
93. Reversal of ethanol intoxications in humans: An assessment in the efficacy of propranolol
94. Reversal of ethanol intoxications in humans: An assessment of the efficacy of L-dopa, aminophylline, and ephedrine
95. Changes in dopamine receptor sensitivity in humans after heavy alcohol intake
96. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
97. Decreases in dopamine receptors but not in dopamine transporters in alcoholics
98. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal
99. Serotonergic and noradrenergic dysregulation in alcoholism: M-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects
100. Allelic association of human dopamine D2 receptor gene in alcoholism
101. Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage
102. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis
103. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal
104. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele
105. Pharmacological treatment for antisocial personality disorder alcoholics: A preliminary study
106. Long-acting injectable bromocriptine does not reduce relapse in alcoholics
107. Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics
108. Association between alcoholism and the dopamine D4 receptor gene
109. DRD4 dopamine receptor genotype and CSF monoamine metabolities in Finnish alcoholics and controls
110. The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: Six polymorphisms tested separately and as haplotypes
111. Lack of association between alcohol dependence and D3 dopamine receptor gene in three independent samples
112. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking
113. No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism
114. No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples
115. Effects of ethanol, temperature, and endogenous regulatory factors on the characteristics of striatal opiate receptors
116. [3H]naloxone binding in the human brain: Alcoholism and the TaqI A D2 dopamine receptor polymorphism
117. Characteristics of receptors and enzymes in brains of human alcoholics
118. Central deficiency of beta-endorphin in alcohol addicts
119. Implication of the endogenous opioid system in excessive ethanol consumption
120. Naltrexone in the treatment of alcohol dependence
121. Naltrexone and coping skills therapy for alcohol dependence. A controlled study
122. Naltrexone-induced alternations in human ethanol intoxication
123. Naltrexone increases the latency to drink alcohol in social drinkers
124. Experience of a "slip" among alcoholics treated with naltrexone or placebo
125. Effect of naltrexone on alcohol "high" in alcoholics
126. Naltrexone in the treatment of alcohol dependence
127. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
128. Mu opioid receptor gene variants: Lack of association with alcohol dependence
129. Allele frequencies of the preproenkephalin A (PENK) gene CA repeat in Asians, African-Americans, and Caucasians: Lack of evidence for different allele frequencies in alcoholics
130. Interaction of pregnanolone and pregnenolone sulfate with ethanol and pentobarbital
131. The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats
132. Ethanol-like discriminative stimulus effects of the neurosteroid 3 alpha-hydroxy-5-alpha-pregnan-20-one in female Macaca fascicularis monkeys
133. Anxiolytic effects of steroid hormones during the estrous cycle. Interactions with ethanol
134. Progesterone metabolite allopregnanolone in women with premenstrual syndrome
135. Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis)
136. Alcohol consumption and menstrual distress in women at higher and lower risk for alcoholism
137. Acute effects of triazolam in women: Relationships with progesterone, estradiol and allopregnanolone
138. Effects of L-type voltage-sensitive calcium channel modulators on the discriminative stimulus effects of ethanol in rats
139. Nimodipine in acute alcohol withdrawal state
140. Neurocircuitry targets in ethanol reward and dependence